6-6

Distribution of number of hogs (left scale) and pounds of pork product (right scale) with various melamine tissue concentrations,

130

6-7

A decision tree for a testing-with-intervention decision involving infant formula and hog feed,

134

6-8

Potential outcomes of a decision to test infant formula but not animal feed, assuming a test without error, and interventions if the test result is positive,

135

6-9

Tree for the decision to test formula but not feed, including uncertainty about test accuracy,

136

2-1

Summary of Attributes and Metrics,

33

3-1

Risk Attributes for Mitigation-Selection Decision for Biologics,

49

3-2

Estimated Numbers and Rates of Deaths and Illnesses from Rotavirus Disease in the Absence of Vaccination,

55

3-3

Example Calculation of Estimated Number of Deaths and Illnesses from Rotavirus Disease and RRV-TV-Induced Intussusceptions for Option to Leave the Vaccine on Market (Based on Median Estimates of all Factors),

59

4-1

Risk Attributes for Targeting Decision for Foods,

69

4-2

Agents Linked to Shrimp-Associated Outbreaks and Cases in the United States, 2001-2005,

79

5-1

Risk Attributes for Strategic-Investment Decision for Medical Devices,

96

5-2

Mortality Estimates,

99

6-1

Risk Attributes for Targeting Decision that Spans Food and Drug Administration Centers,

116

6-2

Formula Consumption by Age,

118

6-3

Estimated Dose for Infants Consuming Formula with Melamine at 100 ppm in Dry Formula,

120

6-4

Estimates of Mortality and Morbidity from Melamine Contamination in Infant Formula for the Hypothesized Dose-Response Relationship Incorporating Uncertainty in Exposure and Dose,

124

6-5

Concentration of Hog Production in 2006,

128

6-6

Melamine Doses to Humans Who Consume Pork with Various Melamine Tissue Concentrations,

131